Abnormal cervical cytology in women eligible for IVF

Human Reproduction

Volumn 21, Issue 9, 2006, Pages 2359-2363

  van Hamont, D ^a   Nissen, L H C ^a   Siebers, A G ^a   Hendriks, J C M ^a   Melchers, W J G ^a   Kremer, J A M ^a   Massuger, L F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case control study; Cervical cytology; Screening; Sexually transmitted infections; Subfertility

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; PROBABILITY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE;

CHLAMYDIA TRACHOMATIS; HUMAN PAPILLOMAVIRUS;

EID: 33749561828     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del132     Document Type: Article

References (41)

1. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T et al. (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285,47-51.
2. Arbeit JM, Howley PM and Hanahan D (1996) Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 93,2930-2935.
3. Bjercke S and Purvis K (1993) Characteristics of women under fertility investigation with IgA/IgG seropositivity for Chlamydia trachomatis. Eur J Obstet Gynecol Reprod Biol 51,157-161.
4. Boon ME, van Ravenswaay Claasen HH and Kok LP (2002) Urbanization and baseline prevalence of genital infections including Candida, Trichomonas, and human papillomavirus and of a disturbed vaginal ecology as established in the Dutch Cervical Screening Program. Am J Obstet Gynecol 187,365-369.
5. Boon ME, van Ravenswaay Claasen HH, van Westering RP and Kok LP (2003) Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix. Cancer 99,4-8.
6. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE and Fortenberry JD (2005) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191,182-192.
7. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M et al. (2001) An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10,1021-1027.
8. Centers for Disease Control and Prevention (1996) Sexually Transmitted Disease Surveillance, 1995. US Department of Health and Human Services, Public Health Service, Atlanta.
9. Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C and McGoogan E (2005) Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 58,946-950.
10. den Hartog JE, Land JA, Stassen FR, Kessels AG and Bruggeman CA (2005) Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility. Hum Reprod 20,986-990.
11. Eckert LO, Hawes SE, Wolner-Hanssen P, Money DM, Peeling RW, Brunham RC, Stevens CE, Eschenbach DA and Stamm WE (1997) Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis 175,1453-1458.
12. Felley-Bosco E (1998) Role of nitric oxide in genotoxicity: Implication for carcinogenesis. Cancer Metastasis Rev 17,25-37.
13. Friedek D, Ekiel A, Romanik M, Chelmicki Z, Chelmicki A and Martirosian G (2005) Impact of Chlamydia trachomatis and HPV infection among sexually active teenage girls in Upper Silesia, Poland. J Korean Med Sci 20,704-705.
14. Gloss B, Bernard HU, Seedorf K and Klock G (1987) The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 6,3735-3743.
15. van Ham MA, Melchers WJ, Hanselaar AG, Bekkers RL, Boonstra H and Massuger LF (2002) Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle. Br J Cancer 87,373-376.
16. Hanselaar AG (2002) Criteria for organized cervical screening programs. Special emphasis on The Netherlands Program. Acta Cytol 46,619-629.
17. Hildesheim A, Reeves WC, Brinton LA, Lavery C, Brenes M, De La Guardia ME, Godoy J and Rawls WE (1990) Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers. Int J Cancer 45,860-864.
18. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM and Desai KM (1985) Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 291,1693-1697.
19. Ismail SM, Colclough AB, Dinnen JS, Eakins D, Evans DM, Gradwell E, O'Sullivan JP, Summerell JM and Newcombe R (1990) Reporting cervical intra-epithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement. Histopathology 16,371-376.
20. Klinkhamer PJ, Vooijs GP and de Haan AF (1988) Intraobserver and interobserver variability in the diagnosis of epithelial abnormalities in cervical smears. Acta Cytol 32,794-800.
21. Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102,3-8.
22. Lai YM, Yang FP and Pao CC (1996) Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells. Fertil Steril 65,1026-1030.
23. Lai YM, Lee JF, Huang HY, Soong YK, Yang FP and Pao CC (1997) The effect of human papillomavirus infection on sperm cell motility. Fertil Steril 67,1152-1155.
24. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT et al. (1996) Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study. BMJ 312,537-539.
25. Lundqvist M, Westin C, Lundkvist O, Simberg N, Strand A, Andersson S and Wilander E (2002) Cytologic screening and human papilloma virus test in women undergoing artificial fertilization. Acta Obstet Gynecol Scand 81,949-953.
26. Melchers WJ, Bakkers JM, Wang J, de Wilde PC, Boonstra H, Quint WG and Hanselaar AG (1999) Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 155,1473-1478.
27. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley K, Brinton LA, Delgado G, Jones S, Tchabo JG et al. (1990) Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 50,4670-4675.
28. Pao CC, Yang FP and Lai YM (1996) Preferential retention of the E6 and E7 regions of the human papilloma virus type 18 genome by human sperm cells. Fertil Steril 66,630-633.
29. Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, Meijer CJ and Kenemans P (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 61,306-311.
30. Rintala MA, Pollanen PP, Nikkanen VP, Grenman SE and Syrjanen SM (2002) Human papillomavirus DNA is found in the vas deferens. J Infect Dis 185,1664-1667.
31. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM and Unger ER (2005) Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162,668-675.
32. Silins I, Ryd W, Strand A, Wadell G, Tornberg S, Hansson BG, Wang X, Arnheim L, Dahl V, Bremell D et al. (2005) Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116,110-115.
33. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, van den Brule AJ, Franceschi S and Peeling RW (2004) Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer 111,431-439.
34. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK and Stamm WE (1993) Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 138,143-153.
35. Strehler E, Sterzik K, Malthaner D, Hoyer H, Nindl I and Schneider A (1999) Influence of ovarian stimulation on the detection of human papillomavirus DNA in cervical scrapes obtained from patients undergoing assisted reproductive techniques. Fertil Steril 71,815-820.
36. van Valkengoed I, Postma MJ, Morre SA, van den Brule AJ, Meijer CJ, Bouter LM and Boeke AJ (2001) Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex Transm Infect 77,276-282.
37. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189,12-19.
38. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G and Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341,1633-1638.
39. Woodhouse SL, Stastny JF, Styer PE, Kennedy M, Praestgaard AH and Davey DD (1999) Interobserver variability in subclassification of squamous intraepithelial lesions: Results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 123,1079-1084.
40. Yobs AR, Plott AE, Hicklin MD, Coleman SA, Johnston WW, Ashton PR, Rube IF, Watts JC, Naib ZM, Wood RJ et al. (1987) Retrospective evaluation of gynecologic cytodiagnosis. II. Interlaboratory reproducibility as shown in rescreening large consecutive samples of reported cases. Acta Cytol 31,900-910.
41. Young NA, Naryshkin S, Atkinson BF, Ehya H, Gupta PK, Kline TS and Luff RD (1994) Interobserver variability of cervical smears with squamous-cell abnormalities: A Philadelphia study. Diagn Cytopathol 11,352-357.